Spyre Therapeutics (SYRE) Files Mixed Shelf
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts SYRE Hot Sheet
Join SI Premium – FREE
Spyre Therapeutics (NASDAQ: SYRE) has filed mixed shelf of:
COMMON STOCK
PREFERRED STOCK
DEBT SECURITIES
WARRANTS
UNITS
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- RBC Capital Downgrades Perspective Therapeutics Inc (CATX) to Sector Perform
- Kearny Financial (KRNY) PT Lowered to $10.50 at Raymond James
- Stem notified of NYSE noncompliance over market cap and equity
Create E-mail Alert Related Categories
Corporate News, Equity OfferingsRelated Entities
Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
